Skip to main content
. 2019 Jun 4;2019:baz060. doi: 10.1093/database/baz060

Figure 5.

Figure 5

Classification of biomarkers (A) and biomarker-drug-tumour combinations (B) according to the evidence level (preclinical, clinical or guidelines).